# Belpointe PREP, LLC: financial statements, quarterly

OZ · NYSE · CIK 1807046 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oz.md) · [Financials](/companies/oz/financials.md) · [Filings](/companies/oz/filings.md) · [Insiders](/companies/oz/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/oz/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.5](/filings/0001493152-24-045229.md) | [0.5 d](/filings/0001641172-25-001569.md) | [0.3](/filings/0001641172-25-010410.md) | [0.4](/filings/0001493152-25-011618.md) | [0.9](/filings/0001493152-25-022469.md) | [1.1 d](/filings/0001493152-26-011713.md) | [1.7](/filings/0001493152-26-022556.md) | [2.0](/filings/0001493152-26-035992.md) | [2.4](/filings/0001493152-25-022469.md) | [3.1 d](/filings/0001493152-26-011713.md) | [4.2](/filings/0001493152-26-022556.md) | [5.4](/filings/0001493152-26-035992.md) |
| Interest expense | $m | not reported | not reported | [0.7](/filings/0001493152-24-019241.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(3.3)](/filings/0001493152-24-045229.md) | [(4.2) d](/filings/0001641172-25-001569.md) | [(4.0)](/filings/0001641172-25-010410.md) | [(4.7)](/filings/0001493152-25-011618.md) | [(6.9)](/filings/0001493152-25-022469.md) | [(8.2) d](/filings/0001493152-26-011713.md) | [(8.6)](/filings/0001493152-26-022556.md) | [(7.6)](/filings/0001493152-26-035992.md) | [(12.1)](/filings/0001493152-25-022469.md) | [(11.7) d](/filings/0001493152-26-011713.md) | [(10.7)](/filings/0001493152-26-022556.md) | [(9.2)](/filings/0001493152-26-035992.md) |
| Diluted EPS | $ per share | [(0.92)](/filings/0001493152-24-045229.md) | not reported | [(1.10)](/filings/0001641172-25-010410.md) | [(1.30)](/filings/0001493152-25-011618.md) | [(1.90)](/filings/0001493152-25-022469.md) | not reported | [(2.35)](/filings/0001493152-26-022556.md) | [(2.06)](/filings/0001493152-26-035992.md) | [(3.21)](/filings/0001493152-25-022469.md) | not reported | [(2.75)](/filings/0001493152-26-022556.md) | [(2.37)](/filings/0001493152-26-035992.md) |
| Basic EPS | $ per share | [(0.92)](/filings/0001493152-24-045229.md) | not reported | [(1.10)](/filings/0001641172-25-010410.md) | [(1.30)](/filings/0001493152-25-011618.md) | [(1.90)](/filings/0001493152-25-022469.md) | not reported | [(2.35)](/filings/0001493152-26-022556.md) | [(2.06)](/filings/0001493152-26-035992.md) | [(3.21)](/filings/0001493152-25-022469.md) | not reported | [(2.75)](/filings/0001493152-26-022556.md) | [(2.37)](/filings/0001493152-26-035992.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [15.7](/filings/0001493152-24-045229.md) | [20.1](/filings/0001641172-25-001569.md) | [29.2](/filings/0001641172-25-010410.md) | [24.7](/filings/0001493152-25-011618.md) | [24.0](/filings/0001493152-25-022469.md) | [24.7](/filings/0001493152-26-011713.md) | [23.0](/filings/0001493152-26-022556.md) | [25.0](/filings/0001493152-26-035992.md) | [29.6](/filings/0001493152-25-022469.md) | [24.3](/filings/0001493152-26-035992.md) | [19.6](/filings/0001493152-26-022556.md) | [15.6](/filings/0001493152-26-035992.md) |
| Total assets | $m | [361](/filings/0001493152-23-041080.md) | [382](/filings/0001641172-25-001569.md) | [451](/filings/0001493152-24-037655.md) | [476](/filings/0001493152-24-037660.md) | [496](/filings/0001493152-24-045229.md) | [518](/filings/0001493152-26-011713.md) | [537](/filings/0001641172-25-010410.md) | [557](/filings/0001493152-25-011618.md) | [571](/filings/0001493152-25-022469.md) | [564](/filings/0001493152-26-035992.md) | [566](/filings/0001493152-26-022556.md) | [562](/filings/0001493152-26-035992.md) |
| Total liabilities | $m | [35.0](/filings/0001493152-23-041080.md) | [57.1](/filings/0001641172-25-001569.md) | [129](/filings/0001493152-24-037655.md) | [159](/filings/0001493152-24-037660.md) | [185](/filings/0001493152-24-045229.md) | [214](/filings/0001493152-26-011713.md) | [242](/filings/0001641172-25-010410.md) | [265](/filings/0001493152-25-011618.md) | [287](/filings/0001493152-25-022469.md) | [289](/filings/0001493152-26-035992.md) | [300](/filings/0001493152-26-022556.md) | [304](/filings/0001493152-26-035992.md) |
| Long-term debt | $m | not reported | [19.7](/filings/0001641172-25-001569.md) | [86.9](/filings/0001493152-24-037655.md) | [120](/filings/0001493152-24-037660.md) | [144](/filings/0001493152-24-045229.md) | [177](/filings/0001493152-26-011713.md) | [203](/filings/0001641172-25-010410.md) | [228](/filings/0001493152-25-011618.md) | [251](/filings/0001493152-25-022469.md) | [261](/filings/0001493152-26-035992.md) | [276](/filings/0001493152-26-022556.md) | [279](/filings/0001493152-26-035992.md) |
| Current portion of debt | $m | [0.0](/filings/0001493152-23-041080.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [4.0](/filings/0001493152-24-045229.md) | not reported | [2.6](/filings/0001493152-24-037660.md) | [2.6](/filings/0001493152-24-045229.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.8) d](/filings/0001493152-24-045229.md) | [(1.7) d](/filings/0001641172-25-001569.md) | [(6.6)](/filings/0001641172-25-010410.md) | [1.2 d](/filings/0001493152-25-011618.md) | [(3.3) d](/filings/0001493152-25-022469.md) | [(5.0) d](/filings/0001493152-26-011713.md) | [(6.6)](/filings/0001493152-26-022556.md) | [(2.4) d](/filings/0001493152-26-035992.md) | [(6.0) d](/filings/0001493152-25-022469.md) | [(10.2) d](/filings/0001493152-26-011713.md) | [(6.1)](/filings/0001493152-26-022556.md) | [(3.9) d](/filings/0001493152-26-035992.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,430](/filings/0001493152-23-041080.md) | [3,523](/filings/0001493152-24-037655.md) | [3,527](/filings/0001493152-24-037660.md) | [3,578](/filings/0001493152-24-045229.md) | [3,632](/filings/0001641172-25-010410.md) | [3,632](/filings/0001493152-25-011618.md) | [3,640](/filings/0001493152-25-022469.md) | [3,666](/filings/0001493152-26-022556.md) | [3,697](/filings/0001493152-26-035992.md) | [3,776](/filings/0001493152-25-022469.md) | [3,879](/filings/0001493152-26-022556.md) | [3,902](/filings/0001493152-26-035992.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,381,094 at 2021-11-05, from the cover of the [10-Q filed 2021-11-15](/filings/0001493152-21-028261.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.